• <nav id="c8c2c"></nav>
      • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
      • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
      • <nav id="c8c2c"><sup id="c8c2c"></sup></nav>
        <tr id="c8c2c"></tr>
      • a级毛片av无码,久久精品人人爽人人爽,国产r级在线播放,国产在线高清一区二区

          Home>News Center>China
               
         

        Second human trials of AIDS vaccine to begin
        By Fu Jing (China Daily)
        Updated: 2004-07-17 01:03

        The second human trials of an AIDS vaccine will be held in Beijing, David Ho, the inventor of the AIDS "cocktail" treatment revealed Friday.

        Patients can have their lives extended by at least ten years thanks to "cocktail" treatment, and a US AIDS patient who received the treatment in 1995 is still alive, said Ho.

        "That's the best performance for my treatment," said Ho, who was hired on Friday as adviser to the National Institute of Biological Science in Beijing.

        He also said the second human ADIS vaccine test is going to take place in Beijing after his research team conducted the first in New York last November.

        He said China will be more intensively involved in co-operation in AIDS treatment and vaccine development with his organization.

        "What is most needed (by HIV Positive individuals in China) is treatment," said Ho, director and CEO of the Aaron Diamond Centre based in New York.

        He and his team are now in Yunnan Province to provide "cocktail" treatment to patients.

        Ho said he expects the study will serve as a model for large-scale AIDS treatment in other Chinese provinces and also help raise public awareness with regard to the need for AIDS treatment in China.

        "This would be viewed as the first step," he said, describing the fight against HIV/AIDS in China as a long road.

        He also said the price of AIDS drugs has already made it possible for some patients to receive such treatment. Recent statistics indicated that US patients can spend about US$130 on the treatment.

        "The figure is huge for an African patient but may be affordable for some Chinese," said Ho, adding that the treatment is currently the most effective way to control the illness and prolong the lives of the patients.

        At Friday's meeting with the media, Yang Xiangzhong, a Chinese cloning expert based at the University of Connecticut, suggested that the Chinese Government should form a special team to conduct cloning research, which can be used to treat diseases.

        "China is competitive in cloning technology; I'm strongly against human cloning, except for research in therapy," said Yang, who was famous for cloning sheep and cows.

        "I personally believe China can lead the world in this regard in five to ten years if some encouraging steps are taken."



         
          Today's Top News     Top China News
         

        Quarterly growth slowing slightly

         

           
         

        Six Nobel winners named top science gurus

         

           
         

        China to launch research station in Arctic

         

           
         

        Extreme weather takes toll across nation

         

           
         

        US to impose tariffs on Chinese products

         

           
         

        Hearing on Chongqing gas blowout ends

         

           
          Second human trials of AIDS vaccine to begin
           
          Economy grows 9.7% in the first half of the year
           
          China Netcom to apply for US$1.5b IPO in US
           
          China bans selective abortion to fix imbalance
           
          Sino-US disarmament meeting set for next week
           
          Medlar festival to be held in Ningxia
           
         
          Go to Another Section  
         
         
          Story Tools  
           
          News Talk  
          When will china have direct elections?  
        Advertisement
                 
        a级毛片av无码
        • <nav id="c8c2c"></nav>
          • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
          • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
          • <nav id="c8c2c"><sup id="c8c2c"></sup></nav>
            <tr id="c8c2c"></tr>